Guan B, Li Q, Li X H, Zhou X J
Department of Pathology, Jinshan Branch of Shanghai 6th People's Hospital, Shanghai 201599, Chian.
Department of Pathology, Shanghai Pudong New Area People's Hospital, Shanghai 201299, China.
Zhonghua Yi Xue Za Zhi. 2016 Jul 12;96(26):2070-5. doi: 10.3760/cma.j.issn.0376-2491.2016.26.007.
To identify basal-like breast carcinoma (BLBC)-specific microRNA (miRs) and its target gene and to investigate the distinct biological function.
Krüppel-like factor 12 (KLF12) 3'-UTR was constructed and luciferase reporter assay was performed for target gene. Expression levels of miR including its target genes were analyzed by quantitative real-time polymerase chain reaction (qRT-PCR), Western blot and immunohistochemistry (IHC). Further functional analyses were conducted which included apoptosis.
Luciferase assay showed miR-205 directly targets KLF12 through binding its 3'-UTR (P=0.001 6). QRT-PCR revealed that miR-205 expression levels were exclusively lower in MDA-MB-468 cell lines (P=0.00 7) and BLBC tumor tissues (P=0.007 4; n=3), but KLF12 were highly expressed in MDA-MB-468 cell lines (P=0.003 9); knock-up of miR-205 expression by transfection with its mimics in MDA-MB-468 cells substantially increased miR-205 expression level (P=0.000) and reduced KLF12 expression level (P=0.038). Western blot displayed that KLF12 expression levels were higher in tumor tissues when compared with normal breast tissues (P=0.008 3; n=9). Knock-up of miR-205 expression by transfection with its mimics promoted MDA-MB-468 cells apoptosis (P=0.006 1).
Our results suggest that miR-205 is a miR specific for BLBC which exerts tumor suppression role through negative regulated proto-oncogene KLF12 and promote cell apoptosis. MiR-205 and KLF12 may provide potential diagnosis molecular biomarker and possible new approach for the treatment for BLBC.
鉴定基底样乳腺癌(BLBC)特异性微小RNA(miR)及其靶基因,并研究其独特的生物学功能。
构建Krüppel样因子12(KLF12)3'-非翻译区,并对靶基因进行荧光素酶报告基因检测。通过定量实时聚合酶链反应(qRT-PCR)、蛋白质免疫印迹法和免疫组织化学(IHC)分析miR及其靶基因的表达水平。进行了包括凋亡在内的进一步功能分析。
荧光素酶检测显示miR-205通过结合其3'-非翻译区直接靶向KLF12(P = 0.0016)。qRT-PCR显示,miR-205表达水平在MDA-MB-468细胞系(P = 0.007)和BLBC肿瘤组织(P = 0.0074;n = 3)中显著降低,但KLF12在MDA-MB-468细胞系中高表达(P = 0.0039);在MDA-MB-468细胞中用其模拟物转染上调miR-205表达,显著提高了miR-205表达水平(P = 0.000)并降低了KLF12表达水平(P = 0.038)。蛋白质免疫印迹法显示,与正常乳腺组织相比,肿瘤组织中KLF12表达水平更高(P = 0.0083;n = 9)。用其模拟物转染上调miR-205表达可促进MDA-MB-468细胞凋亡(P = 0.0061)。
我们的结果表明,miR-205是一种BLBC特异性miR,它通过负调控原癌基因KLF12发挥肿瘤抑制作用并促进细胞凋亡。MiR-205和KLF12可能为BLBC提供潜在的诊断分子生物标志物和可能的新治疗方法。